Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers ; volume:20 ; number:1 ; day:12 ; month:6 ; year:2023 ; pages:1-14 ; date:12.2023
Clinical proteomics ; 20, Heft 1 (12.6.2023), 1-14, 12.2023
- Creator
-
Johansson, Camilla
Hunt, Helian
Signorelli, Mirko
Edfors, Fredrik
Hober, Andreas
Svensson, Anne-Sophie
Tegel, Hanna
Forstström, Björn
Aartsma-Rus, Annemieke
Niks, Erik
Spitali, Pietro
Uhlén, Mathias
Szigyarto, Cristina Al-Khalili
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12014-023-09412-1
- URN
-
urn:nbn:de:101:1-2023091913525644422493
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Johansson, Camilla
- Hunt, Helian
- Signorelli, Mirko
- Edfors, Fredrik
- Hober, Andreas
- Svensson, Anne-Sophie
- Tegel, Hanna
- Forstström, Björn
- Aartsma-Rus, Annemieke
- Niks, Erik
- Spitali, Pietro
- Uhlén, Mathias
- Szigyarto, Cristina Al-Khalili
- SpringerLink (Online service)
Other Objects (12)
Survival in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Vascular-targeted therapies for Duchenne muscular dystrophy
Left ventricular noncompaction in Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Strategies for molecular therapy of Duchenne muscular dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
The golden retriever model of Duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Vascular-targeted therapies for Duchenne muscular dystrophy
Left ventricular noncompaction in Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Strategies for molecular therapy of Duchenne muscular dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
The golden retriever model of Duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Vascular-targeted therapies for Duchenne muscular dystrophy
Left ventricular noncompaction in Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Strategies for molecular therapy of Duchenne muscular dystrophy
Improving clinical trial design for Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy